Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0H8RU
|
|||
Former ID |
DNC005984
|
|||
Drug Name |
N-(4-(trifluoromethyl)benzyl)-4-phenoxybenzamide
|
|||
Synonyms |
CHEMBL199074; N-(4-(trifluoromethyl)benzyl)-4-phenoxybenzamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C21H16F3NO2
|
|||
Canonical SMILES |
C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)NCC3=CC=C(C=C3)C(F)(F)F
|
|||
InChI |
1S/C21H16F3NO2/c22-21(23,24)17-10-6-15(7-11-17)14-25-20(26)16-8-12-19(13-9-16)27-18-4-2-1-3-5-18/h1-13H,14H2,(H,25,26)
|
|||
InChIKey |
JDGSUZBWUUXJCN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Two classes of p38alpha MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5274-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.